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Purpose/Objective: Concurrent chemoradiotherapy (CRT) is 
standard of care for patients with locally advanced head and 
neck squamous cell carcinoma (HNSCC). The current 
delineation and treatment planning approach uses a unique 
set of CT images. As a result, the volume change of the gross 
tumor volume (GTV) during RT is not considered. This could 
lead to changes in the initial dose distribution. Adaptive RT 
(ART) could counteract this problem. However, there is 
currently no way to identify suitable patients for ART. 
Diffusion weighted (DWI) MRI characterizes tissues based on 
the random displacement of water protons; quantified using 
the apparent diffusion coefficient (ADC). The aim of this 
study is to investigate if DWI is predictive for volumetric 
changes during RT and can help in the selection of patients 
suitable for ART. 
Materials and Methods: 59 patients with HNSCC with an 
initial tumor volume above 15 cc were included. We have 
chosen this limitation because we believe that the 
volumetrical changes in tumors smaller than 15 cc would 
have no or very small repercussions on initial dose 
distribution. RT was delivered to a dose of 72 Gy (20 x 2 Gy 
daily, followed by 20 x 1, 6 Gy twice daily). Patients received 
an MRI (1,5 Tesla) before RT, 2 and 4 weeks after start of RT.  
ADC values were determined using six b-values 0, 50, 150, 
500, 750 and 1000 s/mm². Volumes were determined on T1-
weighted MRI at all time-points. Pretreatment ADC values 
were correlated with the volumetric change in the tumor at 2 
and 4 weeks during RT in all 59 patients. In 20 of these 
patients ΔADC values at 2 weeks were correlated with the 
volumetric changes at 4 weeks. To determine the strength of 
the correlation a Pearson correlation coefficient was used. A 
p-value ≤0.05 was considered to be statistically significant. 
Results: There was a significantly positive correlation 
between pretreatment ADC value and volumetric change at 2 
weeks during RT (r=0.9; p=0.001). A positive correlation was 
also found with the volumetric changes at 4 weeks, however 
this failed to reach significance (r=0.4; p:0.08). No 
correlation was found between the ΔADC value at 2 weeks 
during RT and the volumetric changes at 4 weeks (r²:0.001; 
p:0.9).  
 
Conclusions: The implementation of ART is limited due to its 
time consuming nature and the inability to select suitable 
patients. We investigated in 59 patients diagnosed with 
HNSCC (with a tumor volume above 15 cc) if DWI 
characteristics could help us in this regard. We saw a positive 
correlation between pretreatment ADC value and the 
anatomical changes of the tumor during RT. Patients with a 
lower pretreatment ADC value appear to have a greater 
volume decrease early during RT, which might be useful in 
the selection of patient who might benefit from ART. We will 
set up a study in the future to validate these results in a 
bigger patient group and to investigate the potential role of 
other functional imaging techniques such as dynamic contrast 
enhanced magnetic resonance imaging (DCE-MRI).  
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Purpose/Objective: Validation of MRI delineation, with and 
without guidelines for tumor delineation, by using the 
histopathology outline from surgical specimens. 
Materials and Methods: Twenty-two patients (median age, 
61 years; range, 49-79 years; two female and 20 male) with 
T3(N=4) or T4 (N=18) laryngeal or hypopharyngeal cancer 
underwent an MRI scan before total laryngectomy. After 
surgery, whole-mount hematoxylin-eosin stained (H&E) 
sections were obtained from the surgical specimen. One 
pathologist delineated the tumor on the H&E sections 
(tumorH&E). The gross tumor volume (GTV) was delineated on 
MR-images by three independent observers in two sessions; 
del1: delineation according to clinical practice, del2: 
guideline based delineation. Guidelines were based on 
guidelines designed for cartilage invasion on MRI1. Areas with 
higher signal intensity on T2 weighted MRI and more 
gadolinium uptake on T1 weighted MRI than the tumor bulk 
were considered as peritumoral changes and not included in 
the GTV. The specimen was reconstructed and registered to 
the MRI scan in order to compare the GTV to the tumorH&E in 
3 dimensions. To compare the GTV delineation with the 
actual tumor, volumes were compared, overlap parameters 
and tumor extensions outside the GTV were determined. The 
overlap was quantified as sensitivity, that is the part of the 
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tumorH&E volume that was included in the GTV and positive 
predictive value (PPV), that is the part of the GTV that 
actually was tumor. The distance from each point of the 
common contour to the closest point on the contour of the 
tumorH&E in 3D orientation was measured for tumor 
extensions outside the GTV. This measure quantifies the 
underestimation of the tumor for each observer. 
Results: In a clinical setting (del1) the median GTV (19.6 ml, 
range; 8.0-68.1 ml) is 2.1 times as large as the tumor volume 
(9.2 ml, range: 3.7-42.7 ml). By use of guidelines (GTV del2: 
14.8 ml, range: 5.67-58.32 ml) this factor was decreased to 
1.6. For the first session (del1), 88% (0.88, range: 0.62-0.96) 
of the tumor was included in the GTV (sensitivity). For del2 
the sensitivity decreased to 82% (0.82, range: 0.57-0.96). The 
GTV of del1 consisted for 46% (0.46, range 0.31-0.71) of 
tumor (PPV). For del2 the overestimation decreased and the 
PPV increased to 55% (0.55, range: 0.40-0.79). Adding margin 
of 2.9 mm around the GTV (del1) would cover 95% of the 
tumor extensions currently missed in the GTV. For del2 this 
amounted to 3.8 mm.  
Conclusions: In a clinical setting the GTV overestimates the 
actual tumor volume as determined by histopathology and 
which improved considerably by the implementation of 
guidelines (figure). These guidelines decreased the sensitivity 
slightly. This might be explained by registration uncertainties 
which appear more prominent when the accuracy of the 
delineation increases.  
1 Becker M et al. Neoplastic invasion of laryngeal cartilage: 
reassessment of criteria for diagnosis at MR imaging. 
Radiology. 2008 Nov;249(2):551-9.  
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Purpose/Objective: Late mucosal ulcers appeared to be 
dose-limiting toxicity (DLT) in a previous phase-I-escalation 
trial for head and neck squamous cell carcinoma (HNC) using 
18F-FDG-PET-CT guided dose-painting-by-numbers (DPBN). A 
prospective randomised phase II trial is currently 
investigating whether 3-phase adaptive DPBN using the 
maximally tolerated dose will result in better locoregional 
control compared to standard IMRT (S-IMRT). This interim 
analysis reports on local (LC), regional (RC), distant control 
(DC), overall survival (OS) and xerostomia, dysphagia and 
mucosal integrity at ≥ 3 months.  
Materials and Methods: From 2011, Q3 to 2014, Q3 34 
patients received primary radio(chemo)therapy for HNC. We 
report on 28 patients who have ended therapy for ≥ 3 
months. Patient, tumor and treatment characteristics can be 
found in Table 1. 
 
 
Figure 1 demonstrates dose prescription protocols (DPP) of 
the DPBN- and S-IMRT group.  
 
 
Results: Median follow-up in living patients was 13 (3-34) 
months. Eight patients deceased: 5 DPBN-patients (due to 
metastases (n = 3), complications after neck dissection for 
regional recurrence (n = 1) and unknown cause (n = 1)) and 3 
S-IMRT patients (due to metastases (n = 2) and aspiration 
pneumonia (n = 1)). 
Local recurrence was seen in n = 2 (14%) in the S-IMRT-group. 
One regional recurrence in elective neck was seen in the 
DPBN-group. Metastases were seen in 5 and 3 patients in the 
DPBN- and S-IMRT-group, respectively. One patient 
interrupted DPBN due to distant metastases after fraction 28 
and deceased 1 month later which made local evaluation at 3 
months impossible. 
At 1 year actuarial LC was 100% and 80% (p = 0.13), RC 90% 
and 100% (p = 0.8), DC 76% and 90% (p = 0.7) and OS 59% and 
92% (p = 0.48) in DPBN and S-IMRT, respectively.  
We unexpectedly observed grade (G)3 and 4 mucosal ulcers in 
1/7 and 3/7 DPBN-patients in DPP1 for which laryngectomy 
and partial mandibulectomy were needed (n = 2) for 
associated chondro- and osteoradionecrosis. In order to avoid 
G4 mucosal LT the DPBN-DPP has been adapted in 2 steps 
(Fig. 1): DPP1 used a median dose prescription that can result 
in increased doses in a GTV with > 50% voxels of low-uptake. 
This median dose prescription was abandoned in DPP2. In 
DPP3 the very-high dose region has been limited to an 
absolute volume of 1.75 cc.  
In DPP2 and DPP3, 1/2 and 1/5 patients had G3 mucosal LT, 
respectively, that healed spontaneously in the patient from 
DPP2 and could't be followed up in the DPP3-patient as he 
deceased due to distant metastases.  
Late G3 dysphagia was seen in 1 and 2 DPBN and S-IMRT 
patients at month 3, respectively. Maximal dysphagia grade 
